Oxfordshire, United Kingdom

Christopher John Yarnold

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 8.8

ph-index = 4

Forward Citations = 50(Granted Patents)


Location History:

  • Didcot, GB (2003 - 2015)
  • Oxfordshire, GB (2013 - 2015)
  • Abingdon, GB (2011 - 2021)
  • Didcot Oxon, GB (2019 - 2021)

Company Filing History:


Years Active: 2003-2021

Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: Unveiling the Innovative Work of Inventor Christopher John Yarnold

Introduction:

Christopher John Yarnold, a prolific inventor, hails from Oxfordshire, GB. With an impressive portfolio of 14 patents to his credit, Yarnold has been at the forefront of developing groundbreaking solutions in the field of antiviral compounds.

Latest Patents:

Yarnold's latest patents revolve around novel compounds designed to combat viral infections and diseases associated with PLA2G16. These compounds, represented by a specific formula, hold promise in treating, preventing, and ameliorating a wide range of viral infections.

Career Highlights:

Throughout his career, Yarnold has made significant contributions to the field of pharmaceuticals and healthcare. Notably, he has worked with esteemed companies such as Vifor International AG and the CHDI Foundation, Inc., where his innovative spirit has flourished.

Collaborations:

In his quest for innovation, Yarnold has collaborated with talented individuals in the industry, including his coworkers Stephen Martin Courtney and Franz Dürrenberger. Together, they have pushed the boundaries of scientific research, bringing forth novel solutions to combat viral illnesses.

Conclusion:

Christopher John Yarnold's dedication to inventing novel antiviral compounds underscores his commitment to advancing healthcare and pharmaceutical research. His unwavering pursuit of innovation continues to inspire the next generation of inventors in the quest for improving global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…